12-2504550-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000719.7(CACNA1C):​c.1114-292C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0782 in 1,483,106 control chromosomes in the GnomAD database, including 4,849 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.068 ( 429 hom., cov: 32)
Exomes 𝑓: 0.079 ( 4420 hom. )

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.556

Publications

11 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-2504550-C-T is Benign according to our data. Variant chr12-2504550-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.127 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.1114-292C>T
intron
N/ANP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.1217+11C>T
intron
N/ANP_001161095.1Q13936-37
CACNA1C
NM_199460.4
c.1114-292C>T
intron
N/ANP_955630.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.1217+11C>T
intron
N/AENSP00000382512.1Q13936-37
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.1114-292C>T
intron
N/AENSP00000382563.1Q13936-12
CACNA1C
ENST00000682544.1
c.1204-292C>T
intron
N/AENSP00000507184.1A0A804HIR0

Frequencies

GnomAD3 genomes
AF:
0.0683
AC:
10362
AN:
151768
Hom.:
428
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0406
Gnomad AMI
AF:
0.0374
Gnomad AMR
AF:
0.0724
Gnomad ASJ
AF:
0.124
Gnomad EAS
AF:
0.135
Gnomad SAS
AF:
0.0790
Gnomad FIN
AF:
0.0412
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0795
Gnomad OTH
AF:
0.0841
GnomAD2 exomes
AF:
0.0760
AC:
18888
AN:
248548
AF XY:
0.0784
show subpopulations
Gnomad AFR exome
AF:
0.0415
Gnomad AMR exome
AF:
0.0506
Gnomad ASJ exome
AF:
0.120
Gnomad EAS exome
AF:
0.139
Gnomad FIN exome
AF:
0.0402
Gnomad NFE exome
AF:
0.0818
Gnomad OTH exome
AF:
0.0796
GnomAD4 exome
AF:
0.0794
AC:
105691
AN:
1331220
Hom.:
4420
Cov.:
21
AF XY:
0.0798
AC XY:
53465
AN XY:
669722
show subpopulations
African (AFR)
AF:
0.0407
AC:
1259
AN:
30954
American (AMR)
AF:
0.0539
AC:
2400
AN:
44524
Ashkenazi Jewish (ASJ)
AF:
0.127
AC:
3235
AN:
25386
East Asian (EAS)
AF:
0.125
AC:
4886
AN:
39066
South Asian (SAS)
AF:
0.0747
AC:
6250
AN:
83676
European-Finnish (FIN)
AF:
0.0420
AC:
2235
AN:
53226
Middle Eastern (MID)
AF:
0.0898
AC:
494
AN:
5504
European-Non Finnish (NFE)
AF:
0.0807
AC:
80116
AN:
992780
Other (OTH)
AF:
0.0858
AC:
4816
AN:
56104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
4907
9814
14720
19627
24534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2846
5692
8538
11384
14230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0682
AC:
10362
AN:
151886
Hom.:
429
Cov.:
32
AF XY:
0.0672
AC XY:
4987
AN XY:
74218
show subpopulations
African (AFR)
AF:
0.0408
AC:
1690
AN:
41410
American (AMR)
AF:
0.0722
AC:
1101
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
431
AN:
3468
East Asian (EAS)
AF:
0.135
AC:
696
AN:
5162
South Asian (SAS)
AF:
0.0782
AC:
375
AN:
4794
European-Finnish (FIN)
AF:
0.0412
AC:
435
AN:
10564
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0795
AC:
5400
AN:
67936
Other (OTH)
AF:
0.0827
AC:
174
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
486
972
1458
1944
2430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0796
Hom.:
1556
Bravo
AF:
0.0713
Asia WGS
AF:
0.0910
AC:
315
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Long QT syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
9.9
DANN
Benign
0.91
PhyloP100
-0.56
PromoterAI
0.0034
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2238087; hg19: chr12-2613716; COSMIC: COSV59776774; API